Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT

Introduction

Germ cell neoplasia in situ (GCNIS)-associated tumors encompass both seminomatous and non-seminomatous germ cell tumors (NSGCT), with teratoma being a subtype of NSGCT [1]. Growing teratoma syndrome (GTS) is a rare benign tumor that manifests as metastases of the teratoma component in patients with germ cell tumors, despite the normalization of tumor markers during and after chemotherapy. It has three main components: clinical enlargement of tumors during or after chemotherapy, normalization of previously elevated tumor markers, and presence of only mature elements upon histologic examination of the tumor [2]. The diagnosis is established by sequential radiological imaging and the presence of mature teratoma remnants in the surgical specimen. These growing teratomas are resistant to chemotherapy and radiation therapy, therefore extensive surgeries may be needed [3]. Patients with disease on imaging, even if stable, should continue to be followed as these lesions can begin to grow even years later [4]. We present a rare case of testicular-derived GTS identified by F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and confirmed by histopathology.

Publication History

Received: 15 January 2024

Accepted after revision: 20 February 2024

Article published online:
14 March 2024

• References

• 1 Al-Obaidy KI, Idrees MT. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features. Adv Anat Pathol 2021; 28: 258-275 DOI: 10.1097/PAP.0000000000000302. (PMID: 33871428)
• 2 Logothetis CJ, Samuels ML, Trindade A. et al. The growing teratoma syndrome. Cancer 1982; 50 (08) 1629-1635 DOI: 10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1. (PMID: 6288220)
• 3 Verma P, Rajaram S, Kottayasamy Seenivasagam RK. et al. Growing teratoma syndrome: a surgical conundrum. BMJ Case Rep 2022; 15 (12) e251821
• 4 Nitecki R, Hameed N, Bhosale P. et al. Growing teratoma syndrome. Int J Gynecol Cancer 2023; 33 (02) 299-303 DOI: 10.1136/ijgc-2022-004265. (PMID: 36746506)
• 5 Dotzauer R, Thomas C, Jäger W. The use of F-FDG PET/CT in testicular cancer. Transl Androl Urol 2018; 7: 875-878 DOI: 10.21037/tau.2018.09.08. (PMID: 30456190)
• 6 Tongaonkar HB, Deshmane VH, Dalal AV. et al. Growing Teratoma Syndrome. Journal of Surgical Oncology 1994; 55: 56-60 DOI: 10.1002/jso.2930550116. (PMID: 8289455)
• 7 Sanchez D, Zudaire JJ, Fernandez JM. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse. BJU Int 2002; 89: 912-916 DOI: 10.1046/j.1464-410x.2002.02779.x. (PMID: 12010239)
• 8 Gorbatiy V, Spiess PE, Pisters LL. The growing teratoma syndrome: Current review of the literature. Indian J Urol 2009; 25: 186-189 DOI: 10.4103/0970-1591.52910. (PMID: 19672343)
• 9 Green DB, La Rosa FG, Craig PG. et al. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors. Korean J Radiol 2021; 22: 1650-1657